The Federal Circuit Issues Guidance on Intervening Rights

March 20, 2012

Reading Time : 2 min

On March 15, 2012, the Federal Circuit issued an en banc opinion providing guidance on the subject of intervening rights in Marine Polymer Technologies, Inc. v. HemCon, Inc. (Fed. Cir. 2011) (en banc). The court split 5-5 on whether to affirm the district court’s claim construction, leaving the district court’s final judgment intact and reinstating a $29.4 million jury verdict in favor of Marine Polymer. The court took the case en banc, however, to address whether intervening rights arise during reexamination “when the patentee limits the claim scope by argument rather than by formal amendment to the claim language.” As an alternative ground for decision, a 6-4 majority agreed that intervening rights attach only when a patentee amends the text of the claim language during reexamination. The opinion is available here.

HemCon, Inc. (“HemCon”) appealed from a judgment of the District Court for the District of New Hampshire holding that HemCon infringes a patent owned by Marine Polymer Technologies, Inc. (“Marine Polymer”). On appeal, a Federal Circuit panel reversed the district court’s decision, concluding that HemCon had acquired intervening rights based on arguments made by Marine Polymer during a parallel reexamination proceeding. Upon reconsideration by the en banc court, the majority stated that, regardless of whether Marine Polymer’s arguments affected the scope of the claims, “they did not ‘amend’ those claims for intervening rights purposes or make them ‘new,’ which is what the statutory language requires.”

Intervening rights is a defense against a patent modified through post-issuance proceedings. The doctrine was developed by courts based on the recognition that substantive changes to the scope of patent claims through a post-issuance proceeding could cause “gross injustice” where a third party―having already begun making, using, or selling a product―later discovers that its previously lawful activities are rendered infringing by the altered patent. 

The doctrine was codified in the Patent Act of 1952. The statute provides, in relevant part, that ex parte and inter partes reexaminations will give rise to intervening rights where “[a]ny proposed amended or new claims [are] determined to be patentable and [are] incorporated into a patent following a reexamination proceeding[.]”  35 U.S.C. § 307(b) (emphasis added). 

Judge Lourie, writing for the majority on the issue of intervening rights, explained that the phrase “amended” is a term of art in the patent prosecution and reexamination context, and “connotes formal changes to the actual language of a claim.” Accordingly, the majority explained that a “claim can[not] be ‘amended’ . . . without changing the claim language itself.”

Judge Dyk, writing for the dissent, characterized the majority’s discussion of intervening rights as dictum given that the issue “was resolved by the affirmance” and was “not properly before [the court] on appeal.” On the merits, the dissent also disagreed with the majority’s interpretation of the statutory language, believing that it directly thwarts the purpose of intervening rights, defeats the public notice function of the patent system, and encourages patent applicants to engage in “improper strategic behavior” during reexaminations.

The majority rejected this view, reasoning that it is “highly unlikely” that requiring a textual amendment for the purposes of intervening rights would create a loophole in the statute by permitting patentees to rely on arguments during reexamination to avoid the creation of intervening rights.

Contact Information

If you have any questions regarding this alert, please contact—

Cono A. Carrano
ccarrano@akingump.com
202.887.4136
Washington, D.C.
Emily C. Johnson
johnsone@akingump.com
202.887.4099
Washington, D.C.

Share This Insight

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.